EndoGastric Solutions is a medical technology company that develops incisionless transoral procedures for the treatment of upper gastrointestinal diseases, including gastroesophageal reflux disease and other GI disorders. It designs and manufactures EsophyX for use in endoluminal, transoral tissue approximation, thickness placation, and ligation in the GI tract. Its EsophyX is also indicated for the treatment of symptomatic chronic gastroesophageal reflux disease in patients who require and respond to pharmacological therapy.
|Employees (est.) (Sept 2020)||71||(+5%)|
EndoGastric Solutions total Funding
EndoGastric Solutions latest funding size
Time since last funding
|a year ago|
EndoGastric Solutions investors
|Canaan Partners, Advanced Technology Ventures, Chicago Growth Partners, Foundation Medical Partners, MPM Capital, Radius Ventures, DeNovo Ventures, Oakwood Medical Investors, SightLine Partners, Accelmed, Flare Capital Partners, CRG, CRG L.P., Canepa Healthcare|
EndoGastric Solutions has 1.11k Twitter Followers. The number of followers has increased 1.8% month over month and increased 2.9% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was EndoGastric Solutions founded?
EndoGastric Solutions was founded in 2002.
Who are EndoGastric Solutions key executives?
EndoGastric Solutions's key executives are Skip Baldino, Brent Ahrens and Michael Burke.
How many employees does EndoGastric Solutions have?
EndoGastric Solutions has 71 employees.
Who are EndoGastric Solutions competitors?
Competitors of EndoGastric Solutions include Hound Labs, Bardy Diagnostics and Isomark.
Where is EndoGastric Solutions headquarters?
EndoGastric Solutions headquarters is located at 18109 NE 76th St #100, Redmond.
Where are EndoGastric Solutions offices?
EndoGastric Solutions has offices in Redmond and San Mateo.
How many offices does EndoGastric Solutions have?
EndoGastric Solutions has 2 offices.
Receive alerts for 300+ data fields across thousands of companies